No Picture
Los Angeles Biotech News

BenchSci raises $70M Series D for drug discovery software; Zentalis touts PhIb ovarian cancer data

Canada’s BenchSci has raised $70 million in a Series D round designed to scale its AI drug discovery platform for scientists working in preclinical research. The company boasts thousands of clients for its software, including 16 of the top 20 pharmaceu… […]

No Picture
Los Angeles Biotech News

City of Hope Opens Phase 2 Clinical Trial to Test If Intake of Mushroom-Powder Tablets Could Slow the Progression of Prostate Cancer

DUARTE, Calif.–(BUSINESS WIRE)–Scientists investigate if City of Hope’s natural supplement derived from white button mushroom could lower prostate-specific antigen levels. […]

No Picture
Los Angeles Biotech News

Galera claims positive update in pancreatic cancer but doesn’t report p-values; Amgen launches Canadian fund in tandem with CCRM

Malvern, PA-based Galera Therapeutics released updated follow-up data Wednesday afternoon for a Phase I/II trial in pancreatic cancer, though it did not reveal any p-values associated with the results. According to the company, after six months of foll… […]

No Picture
Los Angeles Biotech News

Global Genes and Orphan Disease Center of the University of Pennsylvania to Convene Patient Group Leaders, Researchers, Clinicians and Industry for 6th Annual RARE Drug Development Symposium

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes announces the 6th Annual RARE Drug Development Symposium in partnership with the Orphan Disease Center of the University of Pennsylvania. […]

No Picture
Los Angeles Biotech News

ImmunityBio Announces Launch of Phase 2 Trial of IL-15 Superagonist Anktiva With Antiretroviral Therapy to Inhibit HIV Reservoirs

CULVER CITY, Calif.–(BUSINESS WIRE)–ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research has launched a Phase 2 clin… […]

No Picture
Los Angeles Biotech News

ChromaDex to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #earnings–ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., May 6, 2021 at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2021. The financ… […]

No Picture
Los Angeles Biotech News

A new gene therapy player debuts in LA with 2 startup VCs at its back, AbbVie on board with a $90M cash upfront and big plans to upend the field

These days, news of a biotech breaking out of stealth mode with a healthy launch round is not all that unusual. But Capsida just might surprise you in all sorts of ways. Beth Seidenberg Backed by 2 VCs that arrived at the same CalTech scientist’s… […]

No Picture
Los Angeles Biotech News

Montrose Environmental Group Announces New Sustainability-Linked Credit Facility

IRVINE, Calif.–(BUSINESS WIRE)–Montrose Environmental Group, Inc. (the “Company,” “Montrose” or “MEG”) (NYSE: MEG) announced today that the Company has entered into a new sustainability-linked credit agreement. Under the terms of the credit agreement… […]

No Picture
Los Angeles Biotech News

BeiGene’s late stage trial shows promising numbers; Amgen to study sotorasib dosage after FDA recommendation

Big Chinese pharma player BeiGene $BGNE is showing off some promising numbers from its interim analysis of a late-stage, head-to-head trial pitting their BTK drug Brukinsa (zanubrutinib) against Imbruvica. Reporting on 415 of 652 patients in the ALPINE… […]